Lyell Immunopharma (LYEL) Enterprise Value: 59.15M

Lyell Immunopharma, Inc. (LYEL)

9.17 -0.09 (-0.97%) USD | NASDAQ | Oct 05, 09:33

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.

Date	Value
October 02, 2026	59.15M
October 01, 2026	62.66M
September 30, 2026	71.55M
September 29, 2026	67.81M
September 28, 2026	70.38M
September 25, 2026	72.96M
September 24, 2026	79.27M
September 23, 2026	88.87M
September 22, 2026	103.37M
September 21, 2026	98.23M
September 18, 2026	100.10M
September 17, 2026	95.18M
September 16, 2026	94.60M
September 15, 2026	97.76M
September 14, 2026	107.58M
September 11, 2026	122.32M
September 10, 2026	127.94M
September 09, 2026	143.85M
September 08, 2026	159.06M
September 04, 2026	178.71M
September 03, 2026	177.54M
September 02, 2026	192.40M
September 01, 2026	182.34M
August 31, 2026	177.54M
August 28, 2026	182.45M

Date	Value
August 27, 2026	184.33M
August 26, 2026	188.77M
August 25, 2026	204.92M
August 24, 2026	187.37M
August 21, 2026	205.85M
August 20, 2026	201.64M
August 19, 2026	211.23M
August 18, 2026	211.93M
August 17, 2026	159.53M
August 14, 2026	168.88M
August 13, 2026	163.97M
August 12, 2026	174.03M
August 11, 2026	190.64M
August 10, 2026	177.78M
August 07, 2026	186.67M
August 06, 2026	174.97M
August 05, 2026	157.19M
August 04, 2026	160.70M
August 03, 2026	143.62M
July 31, 2026	145.25M
July 30, 2026	163.50M
July 29, 2026	145.96M
July 28, 2026	146.42M
July 27, 2026	145.72M
July 24, 2026	138.00M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks